Form EFFECT CRESCENT BIOPHARMA, INC.

March 4, 2026 6:04 AM UTC
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: March 3, 2026
Accession Number: 0001628280-26-013540
Submission Type: POS AM
CIK: 0001253689
Company Name: CRESCENT BIOPHARMA, INC.
File Number: 333-292600


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings